Newer PET tracers
New PET Tracers — Coming to India
Newer PET tracers are arriving at select Indian centres — but availability is uneven and most evidence is still maturing. If your oncologist has recommended a scan now, no emerging tracer is a reason to delay it.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- FAPI and F-DOPA are here — partially — Both are available at select Indian centres in major cities, not uniformly across the country.
- Evidence is still maturing — Emerging uses are promising but not yet established across NCCN, ASCO or ESMO guidance.
- Access depends on cyclotrons — The number of cyclotron facilities in India is the main limit on how quickly newer tracers reach more cities.
- A needed scan today beats a future scan — If your oncologist has recommended a scan, delaying it for an unavailable tracer carries real clinical risk.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Several newer PET tracers — including FAPI and F-DOPA — are becoming available at select Indian centres, with more in CDSCO review. Most are not yet widely accessible. If your oncologist has recommended a scan now, no emerging tracer is a reason to delay it. The evidence base for each is still maturing.
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city, with no hidden charges. Indicative price, as of September 2026.
How does FAPI PET compare with F-DOPA PET?
| Feature | FAPI PET-CT | F-DOPA PET-CT |
|---|---|---|
| What it targets | Fibroblast activation protein in the tissue surrounding the tumour, not the tumour cell itself | The dopamine synthesis pathway, elevated in certain neuroendocrine and brain tumours |
| Established uses | Staging where FDG gives poor results; some peritoneal, gastric and head and neck tumours | Neuroendocrine tumours, glioma recurrence, phaeochromocytoma and paraganglioma |
| Emerging uses (evidence still maturing) | Planning for FAP-targeted radionuclide therapy; some inflammatory conditions | Parathyroid tumour localisation; movement disorder assessment at select neurology centres |
| Status in India | Available at a growing number of centres in major cities; not yet universal | Available at fewer centres than FAPI; expected to expand as cyclotron capacity grows |
| Works when FDG gives poor results? | Often yes — particularly in low-FDG-avid cancers | Yes — for tumours where dopamine pathway imaging is more informative than glucose metabolism |
| Indicative cost at partner centres | ₹23,999 (indicative, subject to change) | ₹23,999 (indicative, subject to change) |
Which signs mean you should get your scan now, not wait?
- Your oncologist has recommended a specific scan. That recommendation is based on your case today, not a hypothetical future option.
- A newer tracer is not available at a centre near you. Availability is uneven across India.
- No confirmed timeline exists for when a newer tracer will reach your city.
- FDG or Ga-68 PSMA will answer the clinical question your oncologist is asking.
- Your disease needs monitoring now. A scan delayed is a period your team cannot see what is happening.
- No newer tracer is better across all cancers — only for specific tumour types and clinical questions.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Know the cost before you commit
An itemised estimate, plus a check of which schemes you may qualify for.
Which newer PET tracers are entering Indian practice?
FAPI is the most widely discussed newer tracer entering Indian oncology practice. It targets fibroblast activation protein in the cells surrounding a tumour, which means it can image cancers that show low FDG uptake. It is available at an expanding number of private centres in major Indian cities, coordinated through cyclotron facilities.
F-18 PSMA is a fluorine-18 version of PSMA imaging for prostate cancer. Its longer half-life compared with the more common Ga-68 PSMA means it can be transported further from the cyclotron, opening access to centres that cannot use Ga-68 PSMA. It is entering Indian practice where cyclotron access exists.
Further tracers targeting specific receptors in rare cancers are in international clinical trials. Some may enter CDSCO review in coming years. We do not yet know their timelines for Indian availability.
What do the terms FAPI, F-DOPA and CDSCO mean?
- FAPI
- Fibroblast Activation Protein Inhibitor. A tracer that binds to a protein found in the tissue surrounding many tumours, rather than on the tumour cell itself. Useful when FDG does not show the tumour clearly.
- F-DOPA
- Fluorodopa. A radiotracer that follows the dopamine pathway in the body. Used for certain neuroendocrine tumours and areas of brain tumour activity where glucose imaging is less reliable.
- F-18 PSMA
- A fluorine-18 PSMA tracer used mainly in prostate cancer. Its longer half-life compared with Ga-68 PSMA means it can reach centres at a greater distance from the cyclotron — expanding access across India.
- Cyclotron
- The machine that produces short-lived radiotracers on site. The number of cyclotrons in India is the main factor determining how quickly newer tracers become accessible in more cities.
- CDSCO
- Central Drugs Standard Control Organisation. India's regulatory authority for medicines and medical devices, including radiotracers. A tracer must receive CDSCO approval before it can be used in routine clinical practice.
- Theranostics
- Pairing a diagnostic imaging tracer with a matching therapeutic agent using the same molecular target. PSMA in prostate cancer is the best-established example currently available in Indian practice.
Should you delay your scan waiting for a newer tracer?
The direct answer is no. If your oncologist has recommended a PET scan, that recommendation is based on your specific case, what is clinically needed now, and what is available to you.
Newer tracers are genuinely promising — but promising is not the same as approved, available at your centre, or right for your cancer type. Not every newer tracer will be better for every cancer, and access across India is not uniform.
A scan delayed for months waiting for an unconfirmed tracer is a period your disease is unmonitored. That is a real cost with no matching benefit.
If a specific newer tracer is likely to change your management — because FDG has not given clear results, or because your tumour type specifically benefits — your oncologist will raise that directly. Trust that conversation over what you have read online.
A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.
Explore 72 more Specialised Tracers and How PET-CT Compares topics
FAPI, F-DOPA & Newer Tracers
- Amyloid and Tau PET for Dementia
- Can You Choose Your Own Tracer?
- Choline and Fluciclovine PET for Prostate Cancer
- F-18 NaF Bone PET: A Better Bone Scan?
- F-DOPA PET-CT: Uses in Parkinson's and Paraganglioma
- FAPI PET-CT Cost in Hyderabad
- FAPI PET-CT: The Tracer That Finds What FDG Misses
- FAPI vs FDG: When the Newer Tracer Is Better
- FES PET for Hormone-Receptor Breast Cancer
- MIBG Scan vs DOTA PET: Which for Neuroendocrine Disease?
- New PET Tracers Coming to India
- Tracer Availability and Why Your Scan Date Is Fixed
- Which PET Tracer Do You Actually Need?
- Why Specialised Tracers Cost More Than FDG
DOTANOC & DOTATATE PET-CT
- DOTA PET and PRRT (Lu-177 DOTATATE) Therapy
- DOTANOC and DOTATATE PET-CT: What They Are
- DOTANOC vs DOTATATE: Is There a Difference?
- DOTATATE PET-CT Cost in Hyderabad
- False Positives on DOTA PET Scans
- Is DOTA PET Covered by Insurance in India?
- Is DOTATATE PET Available in Hyderabad?
- Preparing for a DOTANOC or DOTATATE Scan
- Reading a DOTA PET Report
- The Krenning Score on Your DOTA PET Report
- When Is a DOTA PET Scan Ordered?
- Why Do I Need Both a DOTA PET and an FDG PET?
PET-CT vs Other Scans
- Can an MRI Replace a PET-CT to Avoid Radiation?
- Choosing Between Scans: A Decision Guide by Question
- Combining PET-CT With MRI in the Same Week
- Diagnostic CT vs the CT Inside a PET-CT
- Do You Need Both a CT and a PET-CT?
- Follow-Up Scanning: Alternating PET With Other Tests
- PET-CT vs Biopsy: Which Actually Diagnoses Cancer?
- PET-CT vs Bone Scan for Bone Metastases
- PET-CT vs CT Scan: What Is the Difference?
- PET-CT vs MRI: Which Do You Need?
- PET-CT vs PET-MRI: Is the Newer Machine Better?
- PET-CT vs Tumour Markers for Follow-Up
- PET-CT vs Ultrasound and Mammography
- PET-CT vs Whole-Body MRI for Screening
- When Is a PET-CT Not the Right Test?
- Why Your Doctor Ordered PET-CT and Not a Cheaper Scan
PSMA PET-CT
- False Positives on PSMA PET
- Is PSMA PET Available in Hyderabad and How Soon?
- Is PSMA PET Covered by Insurance or Aarogyasri?
- PSMA PET Before Prostate Surgery or Radiation
- PSMA PET and Lu-177 PSMA Therapy: The Link
- PSMA PET for Cancers Other Than Prostate
- PSMA PET vs Bone Scan and MRI for Prostate Cancer
- PSMA PET vs Normal FDG PET for Prostate Cancer
- PSMA PET-CT Scan Cost in Hyderabad
- PSMA PET-CT: What It Is and Who Needs It
- PSMA-Avid Lesions: What the Report Means
- Preparing for a PSMA PET-CT Scan
- Reading a PSMA PET Report: PRIMARY and miTNM
- Repeat PSMA Scans: How Often and Why
- Rising PSA With a Negative PSMA Scan: What Now?
- When Should You Get a PSMA PET Scan?
Timing Around Treatment
- Baseline PET-CT Before Starting Treatment: Why It Matters
- Can a PET-CT Be Done During Active Chemotherapy?
- Emergency and Urgent PET-CT: When It Cannot Wait
- How Soon After a Previous PET Can You Have Another?
- Interim vs End-of-Treatment Scanning
- PET-CT After Growth Factor Injections
- PET-CT After Steroids: Does It Affect the Scan?
- PET-CT After a Biopsy: How Long to Wait
- PET-CT Before Surgery: What Surgeons Want to Know
- Scanning Too Early: Why It Wastes Money and Causes Panic
- When Should You Have a PET-CT After Chemotherapy?
- When Should You Have a PET-CT After Immunotherapy?
- When Should You Have a PET-CT After Radiotherapy?
- When Should You Have a PET-CT After Surgery?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
Is FAPI PET-CT available in Hyderabad?
FAPI PET-CT is available at select private imaging centres in Hyderabad. CION coordinates PET imaging through partner centres, and access to newer tracers through that network is expanding. Availability changes as cyclotron facilities are commissioned, so confirm at the time of referral rather than relying on a general answer. Your oncologist will tell you whether FAPI is clinically indicated for your case and arrange access accordingly.
Which cancers benefit most from FAPI PET?
FAPI has shown the most promise for cancers that give poor results on standard FDG PET — including some pancreatic, gastric, biliary and peritoneal tumours, and certain head and neck cancers. ESMO notes the evidence is still maturing, and FAPI is not a replacement for FDG in most situations. It is used where FDG gives insufficient information for a specific clinical question, not as a first-line scan for all cancers.
Is F-DOPA PET the same as DOTA PET?
No — these are different tracers for different purposes. F-DOPA follows the dopamine synthesis pathway and is used for certain neuroendocrine tumours, glioma recurrence and phaeochromocytoma. DOTA PET — such as Ga-68 DOTATATE or DOTATOC — targets somatostatin receptors expressed on neuroendocrine tumour cells. Both can be relevant to neuroendocrine tumour assessment but they answer different clinical questions and are not interchangeable. Your oncologist will specify which applies to your case.
When will newer PET tracers be approved in India?
CDSCO approval timelines are not predictable from outside the regulatory process. Some tracers used internationally for years have not yet completed Indian regulatory review; others move through more quickly. There is no reliable general timeline we can offer here. Your oncologist is better placed to tell you which tracers are currently approved and accessible for your cancer type in your city.
Does CION offer FAPI or F-DOPA scans?
CION does not own imaging equipment — PET-CT is coordinated through partner imaging centres. As FAPI and F-DOPA become available at accredited facilities in Telangana and Andhra Pradesh, access through the CION partner network is expected to expand. For current availability of a specific tracer in your city, ask your CION oncologist directly. A webpage answer cannot stay current with what is actually accessible today.
Is any new tracer better than FDG for all cancers?
No. FDG remains the most widely used and broadly useful PET tracer because most cancers show elevated glucose metabolism. Newer tracers are more useful for specific cancer types or specific clinical questions — not across all cancers. The right tracer is the one that answers your oncologist's specific question about your specific tumour. More options are genuinely good news for some patients, but a newer tracer is not automatically the better choice.